Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Interneuron receives fast track designation for CerAxon

April 9, 1998

MS&D describes novel class of antimigraine agents

April 9, 1998

Advisory committee meeting cancellation announced

April 8, 1998

Abbott discovers new agents for controlling synaptic transmission

April 8, 1998

Study shows Quadramet provides significant relief from bone pain

April 8, 1998

Warner-Lambert announces collaboration with Forest

April 8, 1998

Neurokinin A: a peptide with a potential role in the perception of pain

April 8, 1998

Pfizer NK1 antagonist and ondansetron provide synergistic antiemetic efficacy in clinical trials

April 7, 1998

First clinical trials performed with BMS-181885

April 7, 1998

Metabasis Therapeutics and Pfizer extend ARA research collaboration

April 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.